For Q318, according to BioMedGPS’ SmartTRAK Financial Dashboard, the US Infection Prevention - Vascular Access Adjunct Products market grew +4.3% YoY.
Among the many topics covered in the Q318 Infection Prevention Market Recap are:
Prevention of hospital-acquired infections (HAIs) continues to drive measures and practices to reduce Central Line Associated Bloodstream Infections (CLABSIs) and are creating demand for products that can aid in addressing these issues...
Read the entire Q318 Infection Prevention Market Recap including news, data and analysis*...
*This article can only be viewed by SmartTRAK subscribers to this module. For information on how to subscribe, please click the button below.